These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 23686785)

  • 1. Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
    Eslin D; Lee C; Sankpal UT; Maliakal P; Sutphin RM; Abraham L; Basha R
    Tumour Biol; 2013 Oct; 34(5):2781-9. PubMed ID: 23686785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolfenamic acid inhibits neuroblastoma cell proliferation and induces apoptosis: a novel therapeutic agent for neuroblastoma.
    Eslin D; Sankpal UT; Lee C; Sutphin RM; Maliakal P; Currier E; Sholler G; Khan M; Basha R
    Mol Carcinog; 2013 May; 52(5):377-86. PubMed ID: 22213339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation.
    Sankpal UT; Ingersoll SB; Ahmad S; Holloway RW; Bhat VB; Simecka JW; Daniel L; Kariali E; Vishwanatha JK; Basha R
    Tumour Biol; 2016 Oct; 37(10):14259-14269. PubMed ID: 27581819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of clotam and vincristine enhances anti-proliferative effect in medulloblastoma cells.
    Patil S; Sankpal UT; Hurtado M; Bowman WP; Murray J; Borgmann K; Ghorpade A; Sutphin R; Eslin D; Basha R
    Gene; 2019 Jul; 705():67-76. PubMed ID: 30991098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting specificity protein 1 transcription factor and survivin using tolfenamic acid for inhibiting Ewing sarcoma cell growth.
    Shelake S; Sankpal UT; Paul Bowman W; Wise M; Ray A; Basha R
    Invest New Drugs; 2017 Apr; 35(2):158-165. PubMed ID: 28025760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Survivin Inhibitor for Suppressing Pancreatic Cancer Cells Growth via Downregulating Sp1 and Sp3 Transcription Factors.
    Hurtado M; Sankpal UT; Kaba A; Mahammad S; Chhabra J; Brown DT; Gurung RK; Holder AA; Vishwanatha JK; Basha R
    Cell Physiol Biochem; 2018; 51(4):1894-1907. PubMed ID: 30504717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
    Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
    Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of 13 cis-retinoic acid and tolfenamic acid induces apoptosis and effectively inhibits high-risk neuroblastoma cell proliferation.
    Shelake S; Eslin D; Sutphin RM; Sankpal UT; Wadwani A; Kenyon LE; Tabor-Simecka L; Bowman WP; Vishwanatha JK; Basha R
    Int J Dev Neurosci; 2015 Nov; 46():92-9. PubMed ID: 26287661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of tolfenamic acid and curcumin induces colon cancer cell growth inhibition through modulating specific transcription factors and reactive oxygen species.
    Sankpal UT; Nagaraju GP; Gottipolu SR; Hurtado M; Jordan CG; Simecka JW; Shoji M; El-Rayes B; Basha R
    Oncotarget; 2016 Jan; 7(3):3186-200. PubMed ID: 26672603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-leukemic response of a NSAID, tolfenamic acid.
    Sutphin RM; Connelly SF; Lee CM; Sankpal UT; Eslin D; Khan M; Pius H; Basha R
    Target Oncol; 2014 Jun; 9(2):135-44. PubMed ID: 23609055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clotam enhances anti-proliferative effect of vincristine in Ewing sarcoma cells.
    Shelake S; Sankpal UT; Eslin D; Bowman WP; Simecka JW; Raut S; Ray A; Basha R
    Apoptosis; 2019 Feb; 24(1-2):21-32. PubMed ID: 30610505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular and organismal toxicity of the anti-cancer small molecule, tolfenamic acid: a pre-clinical evaluation.
    Sankpal UT; Lee CM; Connelly SF; Kayaleh O; Eslin D; Sutphin R; Goodison S; Adwan L; Zawia NH; Lichtenberger LM; Basha R
    Cell Physiol Biochem; 2013; 32(3):675-86. PubMed ID: 24030139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolfenamic acid inhibits colon cancer cell and tumor growth and induces degradation of specificity protein (Sp) transcription factors.
    Pathi S; Li X; Safe S
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E53-61. PubMed ID: 23670891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression.
    Liu X; Abdelrahim M; Abudayyeh A; Lei P; Safe S
    Mol Cancer Ther; 2009 May; 8(5):1207-17. PubMed ID: 19435870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.
    Abdelrahim M; Baker CH; Abbruzzese JL; Safe S
    J Natl Cancer Inst; 2006 Jun; 98(12):855-68. PubMed ID: 16788159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice.
    Colon J; Basha MR; Madero-Visbal R; Konduri S; Baker CH; Herrera LJ; Safe S; Sheikh-Hamad D; Abudayyeh A; Alvarado B; Abdelrahim M
    Invest New Drugs; 2011 Feb; 29(1):41-51. PubMed ID: 19851711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.
    Papineni S; Chintharlapalli S; Abdelrahim M; Lee SO; Burghardt R; Abudayyeh A; Baker C; Herrera L; Safe S
    Carcinogenesis; 2009 Jul; 30(7):1193-201. PubMed ID: 19406933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule tolfenamic acid and dietary spice curcumin treatment enhances antiproliferative effect in pancreatic cancer cells via suppressing Sp1, disrupting NF-kB translocation to nucleus and cell cycle phase distribution.
    Basha R; Connelly SF; Sankpal UT; Nagaraju GP; Patel H; Vishwanatha JK; Shelake S; Tabor-Simecka L; Shoji M; Simecka JW; El-Rayes B
    J Nutr Biochem; 2016 May; 31():77-87. PubMed ID: 27133426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptotic effect of tolfenamic acid in androgen receptor-independent prostate cancer cell and xenograft tumor through specificity protein 1.
    Choi ES; Shim JH; Jung JY; Kim HJ; Choi KH; Shin JA; Nam JS; Cho NP; Cho SD
    Cancer Sci; 2011 Apr; 102(4):742-8. PubMed ID: 21241418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin as a therapeutic target in Sonic hedgehog-driven medulloblastoma.
    Brun SN; Markant SL; Esparza LA; Garcia G; Terry D; Huang JM; Pavlyukov MS; Li XN; Grant GA; Crawford JR; Levy ML; Conway EM; Smith LH; Nakano I; Berezov A; Greene MI; Wang Q; Wechsler-Reya RJ
    Oncogene; 2015 Jul; 34(29):3770-9. PubMed ID: 25241898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.